MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
Sponsor: The Foundation for Barnes-Jewish Hospital
A PHASE1 clinical study on Glioblastoma, this trial is completed. The trial is conducted by The Foundation for Barnes-Jewish Hospital and has accumulated 14 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE1
▶ Show 9 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Apr 2017 — Aug 2017 [monthly]
Recruiting PHASE1
Phase: NA → PHASE1
-
Feb 2017 — Apr 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Foundation for Barnes-Jewish Hospital
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • St Louis, United States